The Food and Drug Administration has given priority review to a drug as a treatment for blood-clot disorders, the manufacturer said Monday.

Skin care brand Neutrogena in July will begin offering at retail its new ultra gentle daily cleanser.

A Food and Drug Administration expert panel has recommended against expanding the approval of a Johnson & Johnson drug, the company said.

Appropriately promoting niche brands within the intimacy health space can be a little trickier than the average consumer packaged goods product. And social media isn’t necessarily the ideal platform — an adult may not be as comfortable “liking” an intimacy enhancement product on Facebook to show their brand affinity, for example. 


Drug maker Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat patients with deep vein thrombosis or pulmonary embolism, the company said.

Avon, which recently rejected a bid from Coty, has ended its previously announced search for a new CEO by hiring former Johnson & Johnson executive Sheri McCoy to take the helm.

The March/April 2012 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin, Allegra, Zyrtec, Benadryl, Alavert, Advil Allergy Sinus, Chlor-Trimeton Allergy, Hyland's Seasonal Allergy Relief and Similasan Nasal Allergy Relief.

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating HIV in children.

The Food and Drug Administration has given priority review to a regulatory application from Johnson & Johnson for a drug designed to reduce the risk of complications from internal blood clots.

An executive order from the Obama administration has spurred the Food and Drug Administration to address shortages of two cancer drugs and issue draft guidance for the industry to help prevent future shortages, the agency said Tuesday.

Insulet and LifeScan have entered a partnership through which the latter's OneTouch blood-glucose monitoring technology will be integrated into the former's OmniPod Personal Diabetes Manager.

Subsidiaries of Watson Pharmaceuticals and Johnson & Johnson have settled a lawsuit filed by the latter when Watson attempted to market a generic version of one of its contraceptive drugs.